Wolfgang Miesbach: New Research Reveals Clonogenic Hepatocytes as the Key Drivers of Liver Growth and Gene Therapy Success
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Only 15-20% of newborn hepatocytes generate 90% of adult liver tissue. New research from San Raffaele Telethon Institute characterizes hepatocyte heterogeneity and reveals that ‘clonogenic hepatocytes‘ – a small subset of liver cells in newborn mice – are responsible for most adult liver growth:
- Gene editing by HDR preferentially targets these clonogenic cells, expanding edited liver areas during growth
- Lentiviral vectors show age-dependent efficiency – higher in newborns, lower in adults (reversible with proteasome inhibition)
- Peri-central hepatocyte identity develops after weaning
- Clonogenic hepatocytes co-localize with hematopoietic progenitor cells in specialized tissue niches research
Gene Therapy Impact:
This discovery transforms pediatric gene therapy timing and targeting strategies. Understanding when and which hepatocytes to target could unlock more effective treatments for inherited liver diseases
The team used cutting-edge single-cell/spatial transcriptomics, clonal tracing, and mathematical modeling to map hepatocyte proliferation and maturation after birth
Congratulations to Alessio Cantore, Michela Milani, Francesco Starinieri, Matteo Iannacone, Renato Ostuni, Giulia Bortolussi, Ivan Merelli, Stefano Beretta, Marco Monti!”
Title: Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering
Authors: Michela Milani, Francesco Starinieri, Stefano Beretta, Marco Monti, Cesare Canepari, Francesca Marabotti, Samuel Zambrano, Davide Mazza, Anna Fabiano, Chiara Simoni, Eugenia Cammarota, Monica Volpin, Giulia Bortolussi, Fabio Russo, Mauro Biffi, Marco Genua, Sara Degl’Innocenti, Francesca Sanvito, Renato Ostuni, Andrés F. Muro, Eugenio Montini, Federica Moalli, Matteo Iannacone, Ivan Merelli, Alessio Cantore

Read the full article here.
More recent insights on Hemostasis Today.
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women